Daily FNArena News

Peter Switzer of the Switzer Super Report debates whether Trump’s healthcare failure makes “Sell in May” a distinct possibility.

Michael Gable of Fairmont Equities evaluates the technicals of popular lead indicator, the Dow Transports index.

Kathleen Brooks of City Index warns global equities could potentially face a ‘Trump Tantrum’ as disappointment about a failed Obamacare repeal sinks in.

Base metals player Metals X has two key mines in Western Australia and Tasmania and brokers are upbeat about the prospects.

Investments and record east coast building activity are expected to help Brickworks weather the downturn in Western Australian construction, but some headwinds are on the way.

Craig Parker of Moat Capital suggests little direction is apparent on the charts with the ASX200 beholden to what transpires in the US.

Given poor prospects for growth in PBS revenue, brokers expect Sigma Pharmaceuticals will need to rely more on its expansion into other revenue lines.

Most visitors to the FNArena website are sitting behind a desktop PC. We envisage this will change in the years ahead. Which is why the new FNArena website is customised for mobile usage.

Despite a stronger-than-expected first half result, agricultural chemical supplier Nufarm has retained a cautious outlook. Brokers focus on omega-3 and M&A potential.

Craig Swanger of FIIG Securities discusses why Australia’s property market is just like any other market.